TX-1123

Overview

TX-1123 is a potent protein tyrosine kinase (PTK) inhibitor for Src , eEF2-K, and PKA , and EGFR-K/PKC. TX-1123 is a cyclo-oxygenase ( COX ) inhibitor with IC 50 values of 1.16 μM and 15.7 μM for COX2 and COX1, respectively. TX-1123 has low mitochondrial toxicity. TX-1123 can be used in research of cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CaMK | Products > Signaling Pathways > PKA | Products > Signaling Pathways > EGFR | Products > Signaling Pathways > PKC | Products > Signaling Pathways > COX | Products > Signaling Pathways > Src

Product Information

• Catalog No.: HY-121828
• CAS No.: 157397-06-3
• Molecular Formula: C20H24O3
• Molecular Weight: 312.40
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source